Cash/Burn From SEC Filing For Period: 

Q1' 20


Aimmune Therapeutics

Aimmune Therapeutics is a biopharmaceutical company developing and bringing new treatments to people with potentially life-threatening food allergies.



Burn Rate


Amp Analysis

Pipeline Information

Click drug data to see upcoming trial info and prior data

Drug | Disease

Stage | Exp Date

Prior Data

AR101 (Palforzia)

Peanut Allergy

Quarterly Sales (Approved)

November 2020 (Est)


Egg Allergy

Phase 2


Tree Nut

Multi-Tree Nut Allergy



Recent Posts

See What The Community Is Saying - Click To See Full Post


BINGO #winner #ZGNX #AMRN #AIMT...

*Disclaimer: Information provided on and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon